2018 Biotechnology Research Review
Summary
Several significant developments have aided and accelerated development and growth of markets in biotechnology, in the period of review. Notable recent advancements in biotechnology are CRISPR, Spheroids for drug development, Quantitative Cell Based Assay using high content analysis platform and Luciferase based high-throughput screening assay. Such technologies assure the wide adoption of cell line technologies for drug development, simplify the gene editing process making it cost-effective.
Companies operating in cell line market are investing huge amount in setting up manufacturing units with advanced state of art facility and expanded production facilities.
Gene therapy technology has opened new avenues which places emphasis on curing disease that do not have an effective therapeutic availability. Johnson & Johnson, together with the University of Pennsylvania, is developing a third-generation AAV-based gene therapy for Alzheimer’s disease. The goal is to use AAV viral delivery to initiate the expression of therapeutic anti-Alzheimer’s antibodies in the brain. The research represents a novel way to get biologics into the brain to treat Alzheimer’s disease and other brain diseases. This is expected to pave way for further innovations in AAV-based gene therapy.
- Chapter 1 Foreword
- Foreword
- Chapter 2 Genetic Modification Therapies Clinical Applications (Report BIO159A)
- Study Goals and Objectives
- Reasons for Doing the Study
- Contribution of the Study and for Whom
- Scope and Format
- Methodology
- Information Sources
- Geographical Breakdown
- Analyst’s Credentials
- Related BCC Research Reports
- Summary and Highlights
- Introduction to Genetic Technology
- Genetic Modification Therapies Covered in Report
- Forces Driving the Growth of the Market for Genetic Modification Therapies
- Global Market for Genetic Modification Therapies
- Genetic Modification Therapies Industry
- Genetic Variation and Analysis
- Genetic Modification Therapies
- Genetic Modification Therapy Applications
- Chapter 3 Immunohistochemistry (IHC): Global Markets to 2022 (Report BIO161A)
- Study Goals and Objectives
- Definition of Immunohistochemistry
- Scope of Report
- Intended Audience
- Research Methodology and Information Sources
- Analyst's Credentials
- Related BCC Research Reports
- Summary and Highlights
- Market and Technology Background
- Equipment in the Immunohistochemistry Market
- Factors Affecting the Immunohistochemistry Equipment Market
- Reagents in the Immunohistochemistry Market
- Raw Material Suppliers
- Reagent Manufacturers
- Distributors
- End Users
- Factors Affecting the Immunohistochemistry Reagent Market
- Segmentation by End User
- Hospital and Diagnostics Laboratories
- Research Institutes
- Other (Contract Research Organization and Forensic Laboratories)
- Chapter 4 Biomarker Deals: Terms, Value and Trends, 2008–2018 (Report BIO169A)
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources and Methodology
- Intended Audience
- Analyst’s Credentials
- Related BCC Research Reports
- Summary and Highlights
- Market and Technology Background
- Biomarker Identification and Detection Technologies
- Global Biomarker Market Value and its Segmentation
- Licensing Deals in the Biomarkers Market, 2008–2018
- Chapter 5 Cancer Cell Analysis, Instruments, Consumables and Reagents (Report BIO177A)
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst’s Credentials
- Related BCC Research Reports
- Summary and Highlights
- Current Technologies, Trends and Advancements
- Industry Growth Drivers
- Rising Incidences of Different Types of Cancers Across the Globe
- Growing Importance of Cell Assay-Based Drug Development
- Market Breakdown by End User
- Cell Therapy
- Chapter 6 Genome Editing: Technologies and Global Markets (Report BIO146B)
- Study Goals and Objectives
- Reasons for Doing This Study
- Intended Audience
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Related BCC Research Reports
- Summary and Highlights
- Key Drivers of Market Growth
- Current Genome Editing Technologies
- Impact of Genome Editing
- Comparison of Genome Editing
- Applications of Genome Editing
- Academic Research
- Market Segments by Application
- Chapter 7 Synthetic (Cultured) Meat: Global Market (Report BIO174A)
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst’s Credentials
- Related BCC Research Reports
- Summary and Highlights
- Technology Introduction
- Comparison between Traditional and Synthetic Meat
- Market Potential
- Industry Growth Drivers
- Increasing Meat Consumption Globally
- Market Breakdown by End User
- List of Tables
- Table 1 : Global Market for Genetic Modification Therapies, by Disease Category, Through 2023
- Table 2 : Chemical Building Blocks of DNA and RNA
- Table 3 : Genetic Modification Therapies Covered in Report
- Table 4 : Genetic Modification Platforms
- Table 5 : Key Market Growth Driving Forces of Genetic Modification Therapies
- Table 6 : Global Market for Genetic Modification Therapies, by Delivery Technology, Through 2023
- Table 7 : Characteristics of the Genetic Modification Therapies Industry
- Table 8 : Genetic Variant Types
- Table 9 : Therapeutic Intervention Platforms
- Table 10 : Genetic Modification Approaches
- Table 11 : Near-Term Applications for Genetic Modification Therapies
- Table 12 : Global Immunohistochemistry Market, by Product, Through 2022
- Table 13 : Global Immunohistochemistry Market, by End User, Through 2022
- Table 14 : Various Cancer Research Studies
- Table 15 : Global Biomarkers Licensing, Acquisition and Partnership Deals Market, by Type, 2014–2018
- Table 16 : Biomarker Classification
- Table 17 : Common Techniques Used for Biomarker Identification
- Table 18 : Global Biomarkers Market, Through 2023
- Table 19 : Number of Biomarker Licensing Deals in Different Biotech Sectors, 2008–2018
- Table 20 : Example of Licensing Deals, 2008–2018
- Table 21 : Number of Biomarker Licensing Deals in Different Pathological Sectors, 2008–2018
- Table 22 : Purpose of Biomarker Licensing Deals, 2008–2018
- Table 23 : Global Market for Cancer Cell Analysis, by Product Type, Through 2023
- Table 24 : Current Technologies Used in Cancer Cell Analysis
- Table 25 : Global Prevalence of Cancer, by Type, 2016
- Table 26 : Major Types of Cell-Based Assay Used in HTS for Drug Screening
- Table 27 : Global Market for Cancer Cell Analysis, by End User, Through 2023
- Table 28 : CAR T-Cell Therapy in Immuno-Oncology Medicine Development, 2017
- Table 29 : Development Works Initiated in CAR T Therapy
- Table 30 : Global Market for Genome Editing, by Region, Through 2023
- Table 31 : Global Market for Synthetic (Cultured) Meat, by Source, Through 2027
- Table 32 : Comparison between Traditional and Synthetic Meat
- Table 33 : Global Disposable Household Income, by Country, 2013-2016
- Table 34 : Global Consumption of Meat, by Type, 2014 vs 2017
- Table 35 : Global Projected Meat Production, by Type, 2015-2027
- Table 36 : Global per Capita Meat Consumption, by Region, 2015-2027
- Table 37 : Global Synthetic Meat Market, by End User, Through 2027
- List of Figures
- Figure 1 : Global Market for Genetic Modification Therapies, by Disease Category, 2017-2023
- Figure 2 : Main Principle of Molecular Biology
- Figure 3 : Global Immunohistochemistry Market, by Product, 2016-2022
- Figure 4 : Global Immunohistochemistry Market Shares, by End User, 2016 and 2022
- Figure 5 : Global Biomarkers Licensing, Acquisition and Partnership Deals Market, by Type, 2014–2018
- Figure 6 : Global Market for Cancer Cell Analysis, by Product Type, 2017-2023
- Figure 7 : Applications of Cancer Cell Analysis: A General Overview
- Figure 8 : The Drug Discovery Process: The Assay Development Stage
- Figure 9 : End-User Segmentation
- Figure 10 : CAR T Cell Therapy in Immuno-Oncology Medicine Development, 2017
- Figure 11 : CAR T Cell Therapy Mechanism
- Figure 12 : Private Risk Sharing Contracts Announced, 1990-2017
- Figure 13 : Global Market for Genome Editing, by Region, 2017-2023
- Figure 14 : Global Market for Synthetic (Cultured) Meat, by Source, 2021-2027
- Figure 15 : Evolution of Cultured Meat Industry, 1930-2013
- Figure 16 : Manufacturing Process of Cultured Meat
- Figure 17 : Global Disposable Household Income, by Country, 2013-2016
- Figure 18 : End Uses of Synthetic Meat